Perrigo Company PLC (NYSE:PRGO)
| 45.34 Delayed Data As of Sep 23 |  -0.03 / -0.07%Today’s Change | 40.01 Today|||52-Week Range 63.86 | -12.23% Year-to-Date |
Latest PRGO News | Press Releases
| Exclusive Interview: The Motley Fool Sits Down With Nano-X Imaging Sep 22 / MotleyFool.com - Paid Partner Content | Dividend Champion And Contender Highlights: Week Of September 13 Sep 12 / Seeking Alpha - Paid Partner Content |
| Perrigo recalls retail supply of inhaled asthma med due to clogging risk Sep 17 / Seeking Alpha - Paid Partner Content | Stocks To Watch: Apple, Snowflake, Pfizer And Moderna In Focus Sep 12 / Seeking Alpha - Paid Partner Content |
| Wall Street Breakfast: The Week Ahead Sep 13 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 45.37 |
| Today’s open | 46.15 |
| Day’s range | 45.34 - 46.40 |
| Volume | 769,028 |
| Average volume (3 months) | 833,541 |
| Market cap | $6.4B |
Data as of 4:00pm ET, 09/23/2020
Growth & Valuation
| Earnings growth (last year) | +13.01% |
| Earnings growth (this year) | +1.02% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +2.24% |
| P/E ratio | 25.9 |
| Price/Sales | 1.46 |
| Price/Book | 1.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACADACADIA Pharmaceutica... | -0.52 | -1.27% |
| ---- | ||
| BHCValeant Pharmaceutic... | +0.01 | +0.06% |
| MYOKMyoKardia Inc | -3.22 | -2.43% |
Data as of 4:01pm ET, 09/23/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $0.85 |
| Annual revenue (last year) | $4.8B |
| Annual profit (last year) | $146.1M |
| Net profit margin | 3.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
